23 articles for S Narayanan
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
31
Discovery of a novel small molecule agonist scaffold for the APJ receptor.

Rti International
2
Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts.

Orchid Chemicals & Pharmaceuticals
10
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms.

Bristol Myers Squibb
39
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist series.

Arena Pharmaceuticals
6
N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.

AstraZeneca
37
Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists.

Arena Pharmaceuticals
5
Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2.

Research Triangle Institute
43
Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonists.

Arena Pharmaceuticals
18
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.

AstraZeneca
7
Lead optimization of 1,4-azaindoles as antimycobacterial agents.

AstraZeneca
9
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.

AstraZeneca
16
Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity.

The University of Mississippi
16
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase.

University of Kansas
19
Synthesis and evaluation of some novel dibenzo[b,d]furan carboxylic acids as potential anti-diabetic agents.

Glenmark Research Center
28
Synthesis and evaluation of some novel isochroman carboxylic acid derivatives as potential anti-diabetic agents.

Glenmark Research Center
1
Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.

Orchid Chemicals and Pharmaceuticals Ltd.
47
Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor.

Rti International
36
Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice.

Rti International
10
In vivo effective dibenzo[b,d]furan-1-yl-thiazoles as novel PDE-4 inhibitors.

Orchid Pharma
37
Identification of potent pyrazole based APELIN receptor (APJ) agonists.

Rti International
3
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.

AstraZeneca
3
Glycosidase inhibitors and uses thereof

Alectos Therapeutics